Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberdeen Uk Sm. Regulatory News (AUSC)

Share Price Information for Aberdeen Uk Sm. (AUSC)

Share Price is delayed by 15 minutes
Get Live Data
496.00    2.00 (0.40%)
Bid:
493.50
Ask:
497.50
Spread: 4.00 (0.811%)
Market Cap: £228.72m
AUSC Live PriceLast checked at - London Stock Exchange

Intraday Aberdeen Uk Sm. Share Chart

Amendment to Management Fee

3 Apr 2025 07:00

RNS Number : 4110D
abrdn UK Smaller Cos. Growth Trust
03 April 2025
 

3 April 2025

 

abrdn UK Smaller Companies Growth Trust plc

Legal Entity Identifier (LEI): 213800UUKA68SHSJBE37

 

 

Amendment to Management Fee

 

The Board of abrdn UK Smaller Companies Growth Trust plc (the "Company") is pleased to announce that it has agreed a change to the terms of the management fee payable by the Company to Aberdeen Investments ("Aberdeen").

 

With effect from 1 April 2025, the Company's management fee will continue to be charged on a tiered basis, but at reduced rates of 0.60% per annum on the first £200 million of the Net Asset Value ("NAV") and 0.55% on NAV above this figure.

 

Prior to 1 April 2025, the Company's management fee was charged at a rate of 0.75% per annum of the NAV up to £175 million, 0.65% above £175 million and below £550 million, and 0.55% above £550 million.

 

Save for this change, all other terms and conditions contained in the Company's Management Agreement remain unchanged.

 

Liz Airey, Chairman of the Company commented "The Board is pleased to announce this change in the management fee with Aberdeen. We believe that this arrangement will reduce the cost of managing the portfolio by approximately 17.5% per annum to the benefit of all shareholders. As this change is being implemented with only three months of the current financial year left to run, the impact will be more limited in the year to 30 June 2025. However, had the new management fee arrangement been in place for the whole of the financial year to 30 June 2024, then the ongoing charges ratio ("OCR") would have been around 0.80%, rather than the reported 0.92%. The Board considers that this revised fee structure makes the Company more competitive.

 

 

For further information, please contact:

 

G Hay Smith

abrdn Holdings Limited

Company Secretary

0131 372 9370

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZGGDKZKGKZM
Date   Source Headline
24th Feb 202611:57 amRNSNet Asset Value(s)
23rd Feb 20265:08 pmRNSTransaction in Own Shares
23rd Feb 202612:38 pmRNSGearing disclosure
23rd Feb 202612:05 pmRNSNet Asset Value(s)
20th Feb 202611:18 amRNSNet Asset Value(s)
19th Feb 202612:21 pmRNSNet Asset Value(s)
18th Feb 202611:00 amRNSNet Asset Value(s)
17th Feb 202610:32 amRNSNet Asset Value(s)
16th Feb 20261:40 pmRNSGearing disclosure
16th Feb 202612:20 pmRNSNet Asset Value(s)
16th Feb 20269:40 amRNSPortfolio disclosure
13th Feb 20265:11 pmRNSTransaction in Own Shares
13th Feb 202612:39 pmRNSNet Asset Value(s)
12th Feb 20265:08 pmRNSTransaction in Own Shares
12th Feb 202611:01 amRNSNet Asset Value(s)
11th Feb 20265:07 pmRNSTransaction in Own Shares
11th Feb 202612:22 pmRNSNet Asset Value(s)
10th Feb 20265:20 pmRNSTransaction in Own Shares
10th Feb 202612:14 pmRNSNet Asset Value(s)
9th Feb 20265:04 pmRNSTransaction in Own Shares
9th Feb 20262:44 pmRNSGearing disclosure
9th Feb 20261:16 pmRNSNet Asset Value(s)
6th Feb 20265:05 pmRNSTransaction in Own Shares
6th Feb 202611:20 amRNSNet Asset Value(s)
5th Feb 20265:11 pmRNSTransaction in Own Shares
5th Feb 20262:00 pmRNSMonth End Net Asset Value(s)
5th Feb 202610:46 amRNSNet Asset Value(s)
4th Feb 20265:07 pmRNSTransaction in Own Shares
4th Feb 202611:05 amRNSNet Asset Value(s)
3rd Feb 20265:14 pmRNSTransaction in Own Shares
3rd Feb 202612:45 pmRNSNet Asset Value(s)
2nd Feb 20265:05 pmRNSTransaction in Own Shares
2nd Feb 20264:11 pmRNSGearing disclosure
2nd Feb 202610:20 amRNSTotal Voting Rights
30th Jan 20265:10 pmRNSTransaction in Own Shares
30th Jan 202612:19 pmRNSNet Asset Value(s)
29th Jan 20265:22 pmRNSTransaction in Own Shares
29th Jan 202612:19 pmRNSNet Asset Value(s)
28th Jan 20265:23 pmRNSTransaction in Own Shares
28th Jan 202611:35 amRNSNet Asset Value(s)
27th Jan 20265:18 pmRNSTransaction in Own Shares
27th Jan 202611:46 amRNSNet Asset Value(s)
27th Jan 202610:13 amRNSCompliance with Market Abuse Regulation
26th Jan 20265:17 pmRNSTransaction in Own Shares
26th Jan 20262:37 pmRNSGearing disclosure
26th Jan 202612:25 pmRNSNet Asset Value(s)
23rd Jan 20265:10 pmRNSTransaction in Own Shares
23rd Jan 202612:27 pmRNSNet Asset Value(s)
22nd Jan 20265:14 pmRNSTransaction in Own Shares
22nd Jan 202611:50 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.